Analyst upgrades, downgrades and initiations: MRK, PALM, DNA, WMT, TEVA ... - Eric Buscemi

Sign Up | Log In | What is SocialPicks?

Analyst upgrades, downgrades and initiations: MRK, PALM, DNA, WMT, TEVA ...
Mar 13, 2009 04:00 PM UTC

Eric Buscemi

Return	Risk
+0.00%	N/A

Tracked Blogger

Profile & Performance

Subscribe to author

Symbol	Sentiment	Start	Return	Closed
PALM	n/a
FTE	n/a
DNA	n/a
ESRX	n/a
TEVA	n/a
SFD	n/a
MRK	n/a
FWLT	n/a
WMT	n/a
ALU	n/a

Via BloggingStocks:

Filed under: Analyst reports, Analyst upgrades and downgrades, Wal-Mart (WMT), Merck and Co (MRK), Alcatel-LucentADS (ALU), Palm Inc (PALM), Genentech Inc (DNA), Smithfield Foods (SFD), Analyst initiations, Teva Pharm Indus ADR (TEVA)

Analyst upgrades:

Bernstein upgraded Merck (NYSE: MRK) to Outperform from Market Perform and raised its target to $30 from $27 citing valuation and its decision to buy Schering-Plough, at what appears to be a reasonable price.

RBC Capital upgraded Palm (NASDAQ: PALM) to Outperform from Sector Perform and raised its target to $12 from $5 as it believes webOS has increased its chances for Smartphone leadership and will increase its attractiveness as an acquisition target.

RW Baird upgraded Alcatel-Lucent (NYSE: ALU) to Outperform from Neutral on valuation as it believes balance sheet risks are overly discounted in the stock, creating a buying opportunity. The firm has a $3 target on shares.

Express Scripts (NASDAQ: ESRX) was raised to Buy from Hold at Argus.

France Telecom (NYSE: FTE) was upgraded at Morgan Stanley to Equal Weight from Underweight.

Foster Wheeler (NASDAQ: FWLT) was upgraded to Conviction Buy from Neutral at Goldman.

Continue reading Analyst upgrades, downgrades and initiations: MRK, PALM, DNA, WMT, TEVA ...

Analyst upgrades, downgrades and initiations: MRK, PALM, DNA, WMT, TEVA ... originally appeared on BloggingStocks on Fri, 13 Mar 2009 11:00:00 EST. Please see our terms for use of feeds.

PermalinkÂ |Â Email thisÂ |Â Comments

Read the rest of original post »

Add Comment

Be the first to comment on this story and earn 2 points.

Your Comment

IN THE PRESS

None of the information contained on SocialPicks.com constitutes a recommendation by SocialPicks or its users that any particular security, portfolio of securities, transaction, or investment strategy is suitable for any specific person. SocialPicks is not responsible for the posts, discussions, and recommendations of the users on the Site. SocialPicks does not provide investment advice. You must make your own independent decisions regarding any security, portfolio of securities, transaction, or investment strategy mentioned on the website. SocialPicks' users' past results are not necessarily indicative of future performance. Neither SocialPicks nor any of its users guarantees any specific outcome or profit, and you should be aware of the real risk of loss in following any strategy or investments discussed on the website. You understand and agree that you use the Site and Services at your own discretion and risk and that you will be solely responsible for any damages that arise from such use. Before acting on any information contained on the website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.